课题基金 / 基金详情

THE ESTABLISHMENT OF JAPAN-ORIGINAL GENE THERAPY BY ANTI-TUMOR ANGIOGENESIS USING DECOY GENE.

THE ESTABLISHMENT OF JAPAN-ORIGINAL GENE THERAPY BY ANTI-TUMOR ANGIOGENESIS USING DECOY GENE.
日本原创的利用诱饵基因抗肿瘤血管生成的基因疗法的建立。
批准号:
20390478
负责人:
ISHIBASHI Hiroaki
金额:
$12.06万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2011

项目摘要

项目成果

ISHIBASHI Hiroaki的其他基金

相似基金

相关文献

中文摘要
翻译
从人肺鳞状细胞癌(QG56)、肺小细胞癌(QG90)和胃腺癌(MKN28)中获得的条件培养基(CM)在缺氧条件下(3% O2)培养,比在常氧培养(20% O2)下获得的条件培养基(CM)在体外增强血管生成活性。牛毛细血管内皮细胞(BCEs)在3% O2培养的CM中形成的管状结构总长度约为1。5(QG56和MKN28)或1。9(QG90)比20% O2时长。用抗碱性成纤维细胞生长因子(bFGF) IgG预孵育CM可减少管的形成。用肝素- sepharose色谱柱对CM和细胞裂解物粗提物进行分离后,所有癌细胞在3% O2下的CM中有丝分裂活性比在20% O2下的CM高2倍左右,而在3% O2下的细胞裂解物中有丝分裂活性下降到20% O2下的40%左右。抗碱性成纤维细胞生长因子(bFGF) IgG几乎完全抑制所有癌细胞CM中bce的有丝分裂活性,而抗血管内皮生长因子(VEGF) IgG则不具有抑制作用。这些结果提示,缺氧条件是肿瘤细胞衍生的bFGF或bFGF样分子生成肿瘤血管的重要原因。
英文摘要
The conditioned media(CM) harvested from human pulmonary squamous cell carcinoma(QG56), pulmonary small cell carcinoma(QG90) and gastric adenocarcinoma(MKN28) cultivated under hypoxic conditions(3% O2), enhanced the angiogenic activity in vitro more than those obtained under normoxic cultivation(20% O2). The total length of the tube structures formed by bovine capillary endothelial cells(BCEs) in the CM cultured at 3% O2 was about 1. 5(QG56 and MKN28) or 1. 9(QG90) times longer than that at 20% O2. Tube formation was diminished by the preincubation of CM with anti-basic fibroblast growth factor(bFGF) IgG. After performing the fractionations of the CM and the crude extracts of cell lysates cultured using a heparin-Sepharose column, the mitogenic activity in the CM from all cancer cells at 3% O2 was about 2 times higher than that in the CM at 20% O2, while it decreased in the cell lysates at 3% O2 to about 40% of those at 20% O2. This mitogenic activity of BCEs in the CM from all cancer cells was almost totally suppressed by anti-basic fibroblast growth factor(bFGF) IgG, but not with anti-vascular endothelial growth factor(VEGF) IgG. These results suggest that the hypoxic condition is an important cause for tumor angiogenesis by bFGF or bFGF-like molecule(s) derived from tumor cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Our approach for early detection of oral cancer using smear cytology
我们使用涂片细胞学早期检测口腔癌的方法
DOI: --
发表时间: 2010
期刊: Korean Association of Oral and Maxillofacial Surgeons
影响因子: --
作者: [Kikuchi M, Ishibashi H, et al.]
通讯作者: et al.
DOI: 10.1007/s00535-011-0515-6
发表时间: 2012-04-01
期刊: JOURNAL OF GASTROENTEROLOGY
影响因子: 6.3
作者: [Yoshikawa, Hiroo, Furuta, Kenji, Sekine, Joji]
通讯作者: Sekine, Joji
Management of tongue squamous cell carcinoma in pregnant women : Report of two Patients
孕妇舌鳞状细胞癌的治疗:两名患者的报告
DOI: --
发表时间: 2009
期刊: Asian J Oral Maxillofac Surg
影响因子: --
作者: [Kondo S, Ishibashi H, Nariai Y, Kato T, Enomoto Y, Karino M, Sekine J]
通讯作者: Sekine J
A fish bone in the tongue: A report of a case
舌头里有鱼刺:一例报告
DOI: 10.1016/j.ajoms.2009.03.001
发表时间: 2010
期刊: Asian Journal of Oral and Maxillofacial Surgery
影响因子: --
作者: [Y. Nariai, C. Yanai, S. Kondo, H. Ishibashi, Masayoshi Egawa, H. Kitagaki, J. Sekine]
通讯作者: J. Sekine
13
    Simple Domestic Gene Therapy against Anti-cancer Angiogenesis with Decoy Oligonucleotides.
    Newky gene therapy using decoy system for degenerative arthritis
    THE DEVELOPMENT OF NEWLY JAPAN-ORIGINAL GENE THERAPY FOR DEGENERATIVE ARTHROSIS USING DECOY GENE.
    • 批准号:
      21659433
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.09万
    • 财政年份:
      2009
    • 负责人:
      ISHIBASHI Hiroaki
    • 依托单位:
    Newly Gene Therapy Targeting Inhibition of the Tumor Angiogenesis Using Decoy System
    • 批准号:
      16390539
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.02万
    • 财政年份:
      2004
    • 负责人:
      ISHIBASHI Hiroaki
    • 依托单位:
    国内基金
    海外基金
    基于HIF-1α乳酸化修饰探讨桃红四物汤调控BMSCs-H型血管新生轴促进骨折愈合的分子机制研究
    • 批准号:
      2026JJ80362
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      周新
    • 依托单位:
    基于多组学揭示乳酸微环境中SPP1+肺癌细胞和SELE+内皮细胞促进血管新生的机制研究
    • 批准号:
      2026JJ81608
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      陈双华
    • 依托单位:
    化痰通络汤调控PIEZO1/ACSL4/VEGF轴阻断线粒体机械转导增强内皮细胞铁死亡抗性促缺血性中风后血管新生的机制研究
    手术应激诱导ESM1分泌通过活化内皮细胞HMMR/FAK/SRC/NFκB信号轴促进卵巢癌血管新生的机制研究
    • 批准号:
      2026JJ82422
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      夏丹
    • 依托单位: